Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Feb
26
2021
RCE Costs Patentee Nearly Two Years of PTA Finnegan
Feb
26
2021
Redemption of Loyalty Points is a Patent-Ineligible Abstract Idea, Federal Circuit Holds Finnegan
Feb
25
2021
The Future of Skinny Labeling in Patent Litigation Will be Reconsidered McDermott Will & Schulte LLP
Feb
25
2021
Doesn’t Scan: Skin Cancer Detection Device Just Combination of Familiar Elements McDermott Will & Schulte LLP
Feb
25
2021
Impossible; Cloud Storage Patent Claims Invalid for Indefiniteness or Not Infringed McDermott Will & Schulte LLP
Feb
24
2021
Podcast Series: Last Month at the Federal Circuit - February 2021 Finnegan
Feb
24
2021
Recoup Your Investment and More – Your Equitable Intervening Rights Are Safe Finnegan
Feb
24
2021
Coming Into Focus: Federal Circuit Reverses PTAB, Finds Independent Claims of Immersion Photography Device Unpatentable as Obvious Finnegan
Feb
23
2021
No Unpatentability in a Successful Motion to Amend Finnegan
Feb
23
2021
Federal Circuit Partially Vacates PTAB Decision in Mixed Victory for Samsung Finnegan
Feb
23
2021
Early RCE Creates Gaps In Patent Term Adjustment Award Foley & Lardner LLP
Feb
22
2021
The Federal Circuit Raises the Enablement Bar for Antibody Patents Polsinelli PC
Feb
18
2021
Old Dawg, New Tricks: Bankruptcy Successor Is Also Inter Partes Re-Exam Successor McDermott Will & Schulte LLP
Feb
18
2021
Attempts to Appeal Institution Decision Is SIPCOed McDermott Will & Schulte LLP
Feb
18
2021
Patent Extension Requires Board or Court Reversal, Multiple Examiner Actions Not Enough McDermott Will & Schulte LLP
Feb
18
2021
Stick to the Fax: Conflicting Statements Made During Prosecution Lead to Indefiniteness McDermott Will & Schulte LLP
Feb
18
2021
2G or Not 2G: Patent License Applies to Future Generation Wireless Networks McDermott Will & Schulte LLP
Feb
17
2021
Copy Cats II: Nexus of Copying Required to Substantiate Non-Obviousness Mintz
Feb
14
2021
Amgen v. Sanofi – How Wands Factors make Biotech Claims “Magically” Disappear Schwegman, Lundberg & Woessner, P.A.
Feb
11
2021
Eight-Month Delay on Transfer Motion Ruling Is “Egregious,” Warrants Stay McDermott Will & Schulte LLP
Feb
11
2021
If You Seek or Browse and Can Find, It’s Publicly Available, but Anticipation Isn’t Obvious and Requires Notice McDermott Will & Schulte LLP
Feb
11
2021
REI’s CO-OP Mark Rides to Registration After TTAB Rejects Per Se Descriptiveness Rule Finnegan
Feb
10
2021
Federal Circuit Agrees to Reconsider Ruling in GSK v. Teva Drug Patent Case Sheppard, Mullin, Richter & Hampton LLP
Feb
9
2021
Federal Circuit Says Automated Systems Are Not Abstract when Tied to Improvements Mintz
Feb
5
2021
Cementing Victory by Accepting Defeat: When Can a Patentee’s Infringement Disclaimer Moot an Appeal of an IPR Decision? Sheppard, Mullin, Richter & Hampton LLP
Jan
28
2021
2020 IP Law Year in Review: Patents McDermott Will & Schulte LLP
Jan
27
2021
JUST OUT: Federal Court Grants Preliminary Approval of Litigation Settlement Involving Alleged Unauthorized Disclosure of Driver Information Squire Patton Boggs (US) LLP
Jan
26
2021
Federal Circuit Denies Sipco’s Appeal of CBM Institution Foley & Lardner LLP
Jan
21
2021
What’s Cookin’? No Likelihood of Confusion Between Two KITCHEN Marks McDermott Will & Schulte LLP
Jan
18
2021
Illumina v. Ariosa – Ariosa Petitions for Cert. Schwegman, Lundberg & Woessner, P.A.
Jan
14
2021
Revenge of the Grammar Nerds: Grammatical Canons Overturn $8.6 Million Jury Infringement Verdict McDermott Will & Schulte LLP
Jan
14
2021
Jetting along the Thin Line between Appellate Standing and Admitting Infringement McDermott Will & Schulte LLP
Jan
14
2021
Patent Owner's Disavowal of Appeal from District Court’s Noninfringement Judgment Moots IPR Appeal McDermott Will & Schulte LLP
Jan
14
2021
State University Challenges Board on Sovereign Immunity in Inter Partes Review McDermott Will & Schulte LLP
Jan
14
2021
New or Not, Object-Oriented Simulation Patent Ineligible Under § 101 McDermott Will & Schulte LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters